Literature DB >> 29025980

Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.

Hossein Jadvar1, Patrick M Colletti2, Roberto Delgado-Bolton3, Giuseppe Esposito4, Bernd J Krause3, Andrei H Iagaru4, Helen Nadel4,5,6, David I Quinn7, Eric Rohren4, Rathan M Subramaniam2, Katherine Zukotynski4, Julie Kauffman4, Sukhjeet Ahuja4, Landis Griffeth4.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29025980     DOI： 10.2967/jnumed.117.197988

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  13 in total

Review 1.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; Meenakshi H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

2.  Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans.

Authors:  Tomomi Nobashi; Claudia Zacharias; Jason K Ellis; Valentina Ferri; Mary Ellen Koran; Benjamin L Franc; Andrei Iagaru; Guido A Davidzon
Journal:  J Digit Imaging       Date:  2020-04       Impact factor: 4.056

3.  Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.

Authors:  Harald Grut; Pål-Dag Line; Trygve Syversveen; Svein Dueland
Journal:  Ann Nucl Med       Date:  2022-10-14       Impact factor: 2.258

4.  Imaging response assessment for oncology: An algorithmic approach.

Authors:  Kathleen Ruchalski; Rohit Dewan; Victor Sai; Lacey J McIntosh; Marta Braschi-Amirfarzan
Journal:  Eur J Radiol Open       Date:  2022-06-07

Review 5.  Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.

Authors:  Richard L Wahl; Panithaya Chareonthaitawee; Bonnie Clarke; Alexander Drzezga; Liza Lindenberg; Arman Rahmim; James Thackeray; Gary A Ulaner; Wolfgang Weber; Katherine Zukotynski; John Sunderland
Journal:  J Nucl Med       Date:  2021-01       Impact factor: 11.082

6.  Improved visualization of breast tissue on a dedicated breast PET system through ergonomic redesign of the imaging table.

Authors:  Michael K O'Connor; Thuy D Tran; Tiffinee N Swanson; Lacey R Ellingson; Katie N Hunt; Dana H Whaley
Journal:  EJNMMI Res       Date:  2017-12-19       Impact factor: 3.138

Review 7.  Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.

Authors:  Clément Bailly; Caroline Bodet-Milin; Mickaël Bourgeois; Sébastien Gouard; Catherine Ansquer; Matthieu Barbaud; Jean-Charles Sébille; Michel Chérel; Françoise Kraeber-Bodéré; Thomas Carlier
Journal:  Cancers (Basel)       Date:  2019-08-31       Impact factor: 6.639

8.  Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma.

Authors:  Nieves Gómez León; Beatriz Aguado Bueno; María Herreros Pérez; Luisa F León Ramírez; Adrián Alegre; Patrick M Colletti; Domenico Rubello; José L Carreras; Roberto C Delgado Bolton
Journal:  Clin Nucl Med       Date:  2021-04-01       Impact factor: 10.782

9.  Results of a Prospective Trial to Compare 68Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors.

Authors:  Lucia Baratto; Akira Toriihara; Negin Hatami; Carina M Aparici; Guido Davidzon; Craig S Levin; Andrei Iagaru
Journal:  Diagnostics (Basel)       Date:  2021-05-30

10.  The requirements of a specialist breast centre.

Authors:  Laura Biganzoli; Fatima Cardoso; Marc Beishon; David Cameron; Luigi Cataliotti; Charlotte E Coles; Roberto C Delgado Bolton; Maria Die Trill; Sema Erdem; Maria Fjell; Romain Geiss; Mathijs Goossens; Christiane Kuhl; Lorenza Marotti; Peter Naredi; Simon Oberst; Jean Palussière; Antonio Ponti; Marco Rosselli Del Turco; Isabel T Rubio; Anna Sapino; Elzbieta Senkus-Konefka; Marko Skelin; Berta Sousa; Tiina Saarto; Alberto Costa; Philip Poortmans
Journal:  Breast       Date:  2020-02-26       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.